Maryland lawmakers will soon vote on a bill that would focus funding on adult stem-cell research for sickle-cell disease.
Life advocates said the move shows that funding embryonic stem-cell research has been a losing proposition, and states are beginning to look to the more successful adult cells, which are already treating over 70 diseases and conditions.
Embryonic stem-cell research involves the destruction of human life.
The legislation is now in the state's House of Delegates.
David Prentice, senior fellow for life sciences at the Family Research Council, said it's encouraging that the Maryland bill that would put resources behind adult stem cells, especially for the treatment of sickle-cell anemia.
"The published science shows bone marrow and cord-blood adult stem cells are the only curative treatment for sickle-cell disease, helping both children and adults," he said. "We desperately need to focus on the patients first and increase funding for adult stem-cell research."
Source: CitizenLink
Publish Date: March 5, 2010
Link to this article.
Send this article to a friend.
